""We've been very intentional and disciplined around capital raising," founder and CEO John Zhao noted, emphasizing that all of Blossom's rounds were oversubscribed but the company chose not to raise more."
"Zhao frames Blossom as a chance to build a 'generational company' in mental health, stating, 'As long as there are human beings, we're going to need healthcare, and mental health is only a larger and larger component of each person's holistic health.'"
"Blossom markets itself as an 'all-in-one AI copilot' that augments psychiatrists' clinical decisions and automates back office tasks, addressing inefficiencies in the psychiatry space."
"Zhao describes existing teletherapy platforms as 'ill-equipped or nonexistent' in the psychiatry space, positioning Blossom's technology as a necessary evolution in mental health care."
Blossom Health has secured $20 million in funding to create an AI-driven psychiatry platform. The New York-based startup aims to provide scalable mental health care without increasing clinic staff. Led by Headline, the funding round included several investors and will add Mathias Schilling to the board. Founder John Zhao emphasizes the importance of mental health and positions Blossom as a solution to the inadequacies of existing teletherapy platforms. The AI copilot will assist psychiatrists and streamline administrative tasks in practices.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]